Registration is open for the Prevounce webinar, "Building a Successful Remote Patient Monitoring Program in Independent Practice." The 45-minute program is scheduled for Tuesday, October 17, at 2:00 PM EDT.
Arthritis is probably one of the most bothersome and frustrating health issues patients face. Classified as both degenerative and chronic, arthritis not only produces pain, but it can also increase symptoms of anxiety and depression, impact independence, contribute to sleep problems, and lead to a host of other chronic health issues due to neglectful self-management of the disorder. Fortunately, patients with the two most common types of arthritis — osteoarthritis and rheumatoid arthritis — are eligible for participation in both chronic care management (CCM) and remote patient monitoring (RPM) services.
The 2024 physician fee schedule (PFS) proposed rule from the Centers for Medicare & Medicaid Services (CMS) had a number of noteworthy proposals. Among them: three potential new care management services intended to help patients, including those with unmet social determinants of health (SDOH) needs and cancer, better navigate and overcome barriers to receiving services and support. These services, which CMS indicated it would pay for separately, are community health integration (CHI), principal illness navigation (PIN), and social determinants of health risk assessments.
The Centers for Medicare & Medicaid Service (CMS) has included numerous proposed changes and additions to remote monitoring and care management in its 2024 physician fee schedule (PFS) proposed rule. We explored the key changes and other important takeaways providers must know about from the proposed rule in a special webinar on July 25 (watch the on-demand recording).
In its 2024 physician fee schedule (PFS) proposed rule, the Centers for Medicare & Medicaid Services is proposing the development and reimbursement of a new service it's calling "principal illness navigation," or PIN.
The Centers for Medicare & Medicaid Services (CMS) has announced a new voluntary primary care initiative that further demonstrates its intent to invest in and grow chronic care management (CCM).
Two Medicare administrative contractors (MACs) that co-hosted a multi-jurisdictional meeting to discuss efficacy of remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) have announced they will not pursue a local coverage determination (LCD) on RPM and RTM for non-implantable devices.
On May 11, 2023, the U.S. COVID-19 public health emergency (PHE) came to an end. While the declaration was largely symbolic, coming more than three years after the PHE was declared, it was still significant from a regulatory perspective in areas including remote patient monitoring (RPM) and telehealth.
One of the more substantial, recent developments in the way healthcare is delivered in the United States concerns remote patient monitoring (RPM), also referred to as remote physiologic monitoring. RPM has technically been around since the early 1970s (with its roots dating back to the 19th century!), but it's been thrown into the spotlight over the past few years thanks to the pandemic and is now experiencing rapid adoption. That comes as no surprise considering the significant and wide-spread benefits of remote patient monitoring.
MultipleMedicare administrative contractors (MACs) recently held a virtual, multi-jurisdictional meeting to discuss efficacy of remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM). The meeting lasted two-plus hours and included commentary from more than 50 subject matter experts, mostly physicians from various specialties who have experience with RPM and RTM.
